BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19557020)

  • 1. Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity.
    Zepeda-Romero LC; Liera-Garcia JA; Gutiérrez-Padilla JA; Valtierra-Santiago CI; Avila-Gómez CD
    Eye (Lond); 2010 May; 24(5):931-3. PubMed ID: 19557020
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
    Kychenthal A; Dorta P
    Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed-onset retinal detachment after an intravitreal injection of ranibizumab for zone 1 plus retinopathy of prematurity.
    Jang SY; Choi KS; Lee SJ
    J AAPOS; 2010 Oct; 14(5):457-9. PubMed ID: 21035077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Our experience after 1765 intravitreal injections of bevacizumab: the importance of being part of a developing story.
    Quiroz-Mercado H; Ustariz-González O; Martinez-Castellanos MA; Covarrubias P; Dominguez F; Sanchez-Huerta V
    Semin Ophthalmol; 2007; 22(2):109-25. PubMed ID: 17564934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan.
    Wu WC; Yeh PT; Chen SN; Yang CM; Lai CC; Kuo HK
    Ophthalmology; 2011 Jan; 118(1):176-83. PubMed ID: 20673589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab.
    Ittiara S; Blair MP; Shapiro MJ; Lichtenstein SJ
    J AAPOS; 2013 Jun; 17(3):323-5. PubMed ID: 23607977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study.
    Kusaka S; Shima C; Wada K; Arahori H; Shimojyo H; Sato T; Fujikado T
    Br J Ophthalmol; 2008 Nov; 92(11):1450-5. PubMed ID: 18621796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.
    O'Keefe M
    Ir Med J; 2011; 104(7):197. PubMed ID: 21957683
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
    dell'Omo R; Kulkarni A; Franks WA
    Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
    [No Abstract]   [Full Text] [Related]  

  • 10. Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab.
    Nonobe NI; Kachi S; Kondo M; Takai Y; Takemoto K; Nakayama A; Hayakawa M; Terasaki H
    Retina; 2009 May; 29(5):579-85. PubMed ID: 19430279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab for retinopathy of prematurity.
    Reynolds JD
    N Engl J Med; 2011 Feb; 364(7):677-8. PubMed ID: 21323546
    [No Abstract]   [Full Text] [Related]  

  • 12. Bevacizumab for retinopathy of prematurity.
    Gole GA; Camuglia JE; Ells AL
    N Engl J Med; 2011 Jun; 364(24):2360-1; author reply 2362. PubMed ID: 21675896
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment on "Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity".
    Er H
    Retina; 2009 Oct; 29(9):1380; author reply 1379-80. PubMed ID: 19934833
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).
    Dorta P; Kychenthal A
    Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.
    Yaz Y; Erol N; Gursoy H; Basmak H; Bilgec MD
    J Pediatr Ophthalmol Strabismus; 2014 Oct; 51 Online():e66-8. PubMed ID: 25333243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different refractive errors in triplets with retinopathy of prematurity treated with bevacizumab.
    Tseng CC; Chen SN; Hwang JF; Lin CJ
    J Pediatr Ophthalmol Strabismus; 2012 Aug; 49 Online():e41-3. PubMed ID: 22881829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Bevacizumab Alter Vascularization Potential in Retinopathy of Prematurity?
    Isaac M; Mireskandari K; Tehrani N
    Ophthalmology; 2016 Sep; 123(9):2042-3. PubMed ID: 27320519
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy.
    Chen E; Park CH
    Retina; 2006; 26(6):699-700. PubMed ID: 16829817
    [No Abstract]   [Full Text] [Related]  

  • 19. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy.
    Arevalo JF; Maia M; Flynn HW; Saravia M; Avery RL; Wu L; Eid Farah M; Pieramici DJ; Berrocal MH; Sanchez JG
    Br J Ophthalmol; 2008 Feb; 92(2):213-6. PubMed ID: 17965108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity.
    Chow CC; Blair MP; Shapiro MJ
    Arch Ophthalmol; 2011 Sep; 129(9):1234-5. PubMed ID: 21911679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.